MoneyWorks4Me

Divi’s Laboratories reports 78% rise in Q4 consolidated net profit

23 May 2022 Evaluate

Divi’s Laboratories has reported results for fourth quarter and year ended March 31, 2022.

The company has reported a rise of 80.96% in its net profit at Rs 882.96 crore for the quarter under review as compared to Rs 487.93 crore for the same quarter in the previous year. Total income of the company increased by 46.19% at Rs 2,545.54 crore for Q4FY22 as compared Rs 1,741.24 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 78.21% in its net profit at Rs 894.64 crore for the quarter under review as compared to Rs 502.02 crore for the same quarter in the previous year. Total income of the company increased by 41.90% at Rs 2,570.83 crore for Q4FY22 as compared Rs 1,811.71 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a rise of 50.84% in its net profit at Rs 2,948.54 crore as compared to Rs 1954.72 crore for the previous year. Total income of the company increased by 31.04% at Rs 8,991.08 crore for year under review as compared to Rs 6,861.14 crore for year ended March 31, 2021.

For the year ended March 31, 2022, on the consolidated basis, the company has reported a rise of 49.19% in its net profit at Rs 2,960.45 crore as compared to Rs 1,984.29 crore for the previous year. Total income of the company increased by 29.04% at Rs 9,073.70 crore for year under review as compared to Rs 7,031.96 crore for year ended March 31, 2021.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..